LABU stock price is trading in a narrow range between $35.60–$37.90, signaling market indecision. Analysts note the biotech sector could see renewed investor interest if macro health policy news turns favorable. Risk management remains key. The biotech fund, LABU gained ~24% and was the top performing levered ETF on the list last week as the sector gained by ~3.5%. Last week’s plunge in U.S. Treasury yields fueled a rally in growth stocks, particularly those in the biotech sector. New drug launches, combined with the prospect of low interest rates and easier access to capital, could provide continued support for this area in the future. These objects, as she would come to learn, have a name: Labubu . After years of rising brand awareness in China, they're taking the U.S. by storm as a hot fashion accessory and hard-to-get collectable.